Thrombin inhibitors and cardiopulmonary bypass.
Merry
Alan
A
Auckland City Hospital, Auckland, New Zealand.
D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use*; D000991:Antithrombins / Q000008:administration & dosage / Q000627:therapeutic use*; D001779:Blood Coagulation Factors; D002315:Cardiopulmonary Bypass / Q000379:methods*; D016903:Drug Monitoring; D006493:Heparin / Q000008:administration & dosage / Q000627:therapeutic use*; D006629:Hirudins / Q000008:administration & dosage; D006801:Humans; D010446:Peptide Fragments / Q000008:administration & dosage / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000627:therapeutic use; D013917:Thrombin / Q000037:antagonists & inhibitors*
D000925:Anticoagulants; D000991:Antithrombins; D001779:Blood Coagulation Factors; D006629:Hirudins; D010446:Peptide Fragments; D011994:Recombinant Proteins; D006493:Heparin; D013917:Thrombin; C074619:bivalirudin